Dorsey Wright & Associates Omeros Corp Transaction History
Dorsey Wright & Associates
- $408 Million
- Q3 2024
Shares
1 transactions
Others Institutions Holding OMER
# of Institutions
123Shares Held
25.2MCall Options Held
228KPut Options Held
630K-
Black Rock Inc. New York, NY4.1MShares$34.6 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY4.01MShares$33.8 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$27.5 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.9MShares$16.1 Million0.01% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.61MShares$13.5 Million0.01% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $529M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...